2987 related articles for article (PubMed ID: 29273476)
1. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
Xu B; Jiang M; Chu Y; Wang W; Chen D; Li X; Zhang Z; Zhang D; Fan D; Nie Y; Shao F; Wu K; Liang J
J Hepatol; 2018 Apr; 68(4):773-782. PubMed ID: 29273476
[TBL] [Abstract][Full Text] [Related]
2. CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy.
Zhang X; Han J; Man K; Li X; Du J; Chu ES; Go MY; Sung JJ; Yu J
J Hepatol; 2016 Jan; 64(1):160-70. PubMed ID: 26394162
[TBL] [Abstract][Full Text] [Related]
3. Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages.
Drummer C; Saaoud F; Jhala NC; Cueto R; Sun Y; Xu K; Shao Y; Lu Y; Shen H; Yang L; Zhou Y; Yu J; Wu S; Snyder NW; Hu W; Zhuo J'; Zhong Y; Jiang X; Wang H; Yang X
Front Immunol; 2023; 14():1113883. PubMed ID: 36776889
[TBL] [Abstract][Full Text] [Related]
4. CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis.
Zhang X; Shen J; Man K; Chu ES; Yau TO; Sung JC; Go MY; Deng J; Lu L; Wong VW; Sung JJ; Farrell G; Yu J
J Hepatol; 2014 Dec; 61(6):1365-75. PubMed ID: 25048951
[TBL] [Abstract][Full Text] [Related]
5. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.
Zhang X; Fan L; Wu J; Xu H; Leung WY; Fu K; Wu J; Liu K; Man K; Yang X; Han J; Ren J; Yu J
J Hepatol; 2019 Jul; 71(1):163-174. PubMed ID: 30914267
[TBL] [Abstract][Full Text] [Related]
6. CD44 is a key player in non-alcoholic steatohepatitis.
Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
[TBL] [Abstract][Full Text] [Related]
7. Caspase-11-Mediated Hepatocytic Pyroptosis Promotes the Progression of Nonalcoholic Steatohepatitis.
Zhu Y; Zhao H; Lu J; Lin K; Ni J; Wu G; Tang H
Cell Mol Gastroenterol Hepatol; 2021; 12(2):653-664. PubMed ID: 33894425
[TBL] [Abstract][Full Text] [Related]
8. Piperine alleviates nonalcoholic steatohepatitis by inhibiting NF-κB-mediated hepatocyte pyroptosis.
Ran S; Song L; Yang H; Yu J; Zhen Y; Liu Q
PLoS One; 2024; 19(3):e0301133. PubMed ID: 38547097
[TBL] [Abstract][Full Text] [Related]
9. ARRB1 inhibits non-alcoholic steatohepatitis progression by promoting GDF15 maturation.
Zhang Z; Xu X; Tian W; Jiang R; Lu Y; Sun Q; Fu R; He Q; Wang J; Liu Y; Yu H; Sun B
J Hepatol; 2020 May; 72(5):976-989. PubMed ID: 31857195
[TBL] [Abstract][Full Text] [Related]
10. Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.
Cruces-Sande M; Vila-Bedmar R; Arcones AC; González-Rodríguez Á; Rada P; Gutiérrez-de-Juan V; Vargas-Castrillón J; Iruzubieta P; Sánchez-González C; Formentini L; Crespo J; García-Monzón C; Martínez-Chantar ML; Valverde ÁM; Mayor F; Murga C
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3655-3667. PubMed ID: 30261289
[TBL] [Abstract][Full Text] [Related]
11. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
Mridha AR; Wree A; Robertson AAB; Yeh MM; Johnson CD; Van Rooyen DM; Haczeyni F; Teoh NC; Savard C; Ioannou GN; Masters SL; Schroder K; Cooper MA; Feldstein AE; Farrell GC
J Hepatol; 2017 May; 66(5):1037-1046. PubMed ID: 28167322
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte-specific deletion of Brg1 alleviates methionine-and-choline-deficient diet (MCD) induced non-alcoholic steatohepatitis in mice.
Kong M; Chen X; Xu H; Wenping ; Fang M; Xu Y
Biochem Biophys Res Commun; 2018 Sep; 503(1):344-351. PubMed ID: 29890136
[TBL] [Abstract][Full Text] [Related]
13. Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion.
He WT; Wan H; Hu L; Chen P; Wang X; Huang Z; Yang ZH; Zhong CQ; Han J
Cell Res; 2015 Dec; 25(12):1285-98. PubMed ID: 26611636
[TBL] [Abstract][Full Text] [Related]
14. [Regulation of electroacupuncture on non-canonical pathway of hepatocellular pyroptosis in rats with nonalcoholic fatty liver disease].
Zhong X; Tang C; Yu M
Zhongguo Zhen Jiu; 2024 May; 44(5):539-45. PubMed ID: 38764104
[TBL] [Abstract][Full Text] [Related]
15. Hepatic vagus nerve regulates Kupffer cell activation via α7 nicotinic acetylcholine receptor in nonalcoholic steatohepatitis.
Nishio T; Taura K; Iwaisako K; Koyama Y; Tanabe K; Yamamoto G; Okuda Y; Ikeno Y; Yoshino K; Kasai Y; Okuno M; Seo S; Sakurai T; Asagiri M; Hatano E; Uemoto S
J Gastroenterol; 2017 Aug; 52(8):965-976. PubMed ID: 28044208
[TBL] [Abstract][Full Text] [Related]
16. Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients.
Khanova E; Wu R; Wang W; Yan R; Chen Y; French SW; Llorente C; Pan SQ; Yang Q; Li Y; Lazaro R; Ansong C; Smith RD; Bataller R; Morgan T; Schnabl B; Tsukamoto H
Hepatology; 2018 May; 67(5):1737-1753. PubMed ID: 29108122
[TBL] [Abstract][Full Text] [Related]
17. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
[TBL] [Abstract][Full Text] [Related]
18. Baicalin attenuates hepatic injury in non-alcoholic steatohepatitis cell model by suppressing inflammasome-dependent GSDMD-mediated cell pyroptosis.
Shi H; Zhang Y; Xing J; Liu L; Qiao F; Li J; Chen Y
Int Immunopharmacol; 2020 Apr; 81():106195. PubMed ID: 32028242
[TBL] [Abstract][Full Text] [Related]
19. Jiangzhi Ligan Decoction Inhibits GSDMD-Mediated Canonical/Noncanonical Pyroptosis Pathways and Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease.
Yin K; Zhou X; Jiang W; Wang L; Dai Z; Tang B
Dis Markers; 2021; 2021():9963534. PubMed ID: 34239622
[TBL] [Abstract][Full Text] [Related]
20. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
[No Abstract] [Full Text] [Related]
[Next] [New Search]
